Differential TLR‐induced cytokine production by human mast cells is amplified by Fcɛ RI triggering
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Summary: Background: Mast cells are mainly present in strategic locations, where they may have a role in defence against parasites and bacteria. These pathogens can be recognized by mast cells via Toll‐like receptors (TLR). Allergic symptoms are often increased in the presence of pathogens at the site of allergen exposure, but it is unknown which cytokines can mediate such an effect. Objective: To study whether an interaction between IgE‐ and TLR‐mediated activation of human mast cells can contribute to exacerbated inflammatory responses. Methods: Peripheral blood‐derived mast cells were stimulated with TLR ligands, in the presence or absence of anti‐IgE triggering, after which degranulation was measured using flow cytometry and cytokine production was evaluated by multiplex assays, and ELISA. For evaluation of allergen‐specific responses, mast cells were sensitized with serum of allergic individuals or controls, after which they were stimulated using allergens in combination with TLR ligands. Results: Simultaneous triggering of mast cells via IgE and TLR ligands greatly enhanced cytokine production but not IgE‐induced degranulation. Different TLR ligands specifically enhanced the differential production of cytokines in conjunction with Fcε RI triggering. Importantly, only TLR‐4 and TLR‐6 were able to induce robust production of IL‐13, an important molecule in allergic reactions. Conclusions & Clinical Relevance: These results indicate that the simultaneous presence of pathogen‐ or danger‐associated signals and Fcε RI triggering via specific IgE can significantly modify mast cell‐mediated allergic reactions via synergistic production of cytokines and inflammatory mediators and provide an explanation of augmented allergic symptoms during infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sutherland, R. E., Olsen, J. S., McKinstry, A., Villalta, S. A., & Wolters, P. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5598 · Cited by 155
Cited by
New developments in mast cell biology
Kalesnikoff, J., & Galli, S. J. (2008) · Nature Immunology · doi:10.1038/ni.f.216 · Cited by 748
Pathogenesis of allergic diseases and implications for therapeutic interventions
Wang, J., Zhou, Y., Zhang, H., Hu, L., Liu, J., Wang, L., Wang, T., Zhang, H., Cong, L., & Wang, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01344-4 · Cited by 376
Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria
Kaplan, A. P., Giménez-Arnau, A. M., & Saini, S. S. (2017) · Allergy · doi:10.1111/all.13083 · Cited by 293
Kucharik, A. H., & Chang, C. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-019-08755-8 · Cited by 122
Hansen, I. S., Hoepel, W., Zaat, S. A. J., Baeten, D. L. P., & den Dunnen, J. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700883 · Cited by 69
“Interestingly, cross-talk with TLRs has previously been described for FcgRIIa (bearing an ITAM sequence in its cytoplasmic tail) on human dendritic cells (15) and macrophages (37), as well as for FcεRI (which signals through the FcRg) on human mast cells (38) and basophils (39).”
BackgroundSelected recent advances in understanding the role of human mast cells in health and disease
Levi-Schaffer, F., Gibbs, B. F., Hallgren, J., Pucillo, C., Redegeld, F., Siebenhaar, F., Vitte, J., Mezouar, S., Michel, M., Puzzovio, P. G., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.01.030 · Cited by 51
Metadata
- Authors
- Suurmond, J., Dorjée, A. L., Knol, E. F., Huizinga, T. W. J., & Toes, R. E. M.
- Venue
- Clinical & Experimental Allergy
- Publisher
- Wiley
- Published
- 2015-03-19
- Volume
- 45
- Issue
- 4
- Pages
- 788-796
- ISSN
- 0954-7894 (ISSN-L)
- 1365-2222
- OpenAlex
- W2169495305
- Cited by
- 46
- References
- 1
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.